MNTA: A few are flat-out ignoring the obvious metrics: How large the US market is, and the fact that the sole generic in the capable hands of a Sandoz-like entity will garner a large fraction of that market. IMO, everything else is mostly noise.
"If we don't succeed, we run the risk of failure." -Dan Quayle